sNDA submission

Related by string. * sNDAs . SNDA : Shanda Interactive SNDA . Shanda Interactive Nasdaq SNDA . #k PMA sNDA . Shanda Nasdaq SNDA . Shanda SNDA . Limited NasdaqGS SNDA . Shanda Interactive NASDAQ SNDA / SUBMISSION . submissions . Submissions . SUBMISSIONS . Submission : Letters submission form . submission triangle choke . submission guillotine choke . BLA submission . MAA submission . spam submissions * *

Related by context. Frequent words. (Click for all words.) 73 BLA submission 66 registrational 66 NDA submission 65 alvimopan 65 confirmatory Phase III 65 confirmatory Phase 3 64 deforolimus 64 Phase 1b trial 64 Phase 2a clinical 63 ponatinib 63 tanespimycin 63 SILENOR TM 63 Marketing Authorization Application 63 Act PDUFA date 63 Phase 2b study 63 Investigational Device Exemption 63 PROPEL trial 62 Phase IIa trial 62 HCV protease inhibitor 62 NUVIGIL 62 phase IIa 62 Phase 2a trial 62 Marketing Authorization Application MAA 62 phase 2a 62 phase IIb 61 TOCOSOL Paclitaxel 61 Genasense R oblimersen 61 Phase Ib 61 LIALDA 61 Biologics License Application BLA 61 Amrubicin 61 Phase 1b clinical 61 Phase 2b clinical 60 pseudobulbar affect PBA 60 Phase III clinical 60 Azedra 60 Anturol 60 PREOS 60 Board DSMB 60 Phase 2b trial 60 Phase III pivotal 60 pivotal Phase III 60 sNDA 60 Phase IIa clinical trials 60 placebo controlled clinical 60 Pivotal Phase III 60 diabetic neuropathic pain 60 Pirfenidone 60 Zelrix 60 BEMA Fentanyl 60 active comparator 60 Icatibant 60 sBLA 60 Cladribine Tablets 60 Complete Response 60 Complete Response letter 59 ROTATEQ 59 FIRAZYR 59 LymphoStat B 59 Phase IIa clinical 59 pralatrexate 59 dose escalation trial 59 Investigational Device Exemption IDE 59 vernakalant oral 59 Phenoptin 59 eniluracil 59 refractory Hodgkin lymphoma 59 PA# [002] 59 TELCYTA 59 Phase IIb trial 59 alogliptin 59 tezampanel 59 Iluvien 59 Phase 2a 59 BCX# 59 Phase 2b 59 Phase IIb clinical 59 Biologics License Application 59 randomized Phase III 59 sodium Injection 59 Acetavance 59 methylnaltrexone 59 bazedoxifene 59 Exalgo 59 OFIRMEV 58 PS# [001] 58 Phase III Clinical Trial 58 romidepsin 58 MONOVISC 58 relapsed refractory multiple myeloma 58 pharmacokinetic studies 58 PXD# 58 Phase 1a 58 Phase 1b 58 Ventavis 58 CR# vcMMAE 58 Empatic 58 aclidinium 58 TORISEL 58 LY# [002] 58 PDUFA date

Back to home page